Reference: World Health Organization. (2024). Mpox. Retrieved from https://www.who.int/news-room/fact-sheets/detail/mpox Summary: Mpox, formerly known as monkeypox, is a viral infection caused by the monkeypox virus, belonging to the Orthopoxvirus genus. The disease presents with symptoms such as fever, rash, headache, muscle pain, and swollen lymph nodes, lasting typically 2–4 weeks. Transmission occurs via close contact with […]
Reference: Turner, H. (2024, August 23). Virologists blow the whistle: MPOX is actually known side-effect of COVID vax! Hal Turner Radio Show. https://halturnerradioshow.com/index.php/news-selections/world-news/virologists-blow-the-whistle-mpox-is-actually-known-side-effect-of-covid-vax Summary: In a controversial assertion, top virologists, including Dr. Poornima Wagh, have challenged the World Health Organization’s (WHO) narrative surrounding the monkey-pox outbreak. They claim that the symptoms attributed to monkey-pox are
Reference: Wilson, R. (2024, August 22). South African group refutes WHO’s declaration of mpox emergency and warns the public about the risks of the vaccine. The Exposé. Retrieved from https://expose-news.com/2024/08/22/south-african-group-refutes-whos-declaration Summary: The South Africa Vaccine Injury Medico-Legal Study Group (SAVIMS) publicly contested the World Health Organisation’s (WHO) declaration of a global health emergency concerning monkeypox,
Johannesburg, South Africa – 18 August 2024 Click here to download PDF of this press release We are deeply concerned about the recent announcements made by Africa CDC Director General Jean Kaseya on 13 August 2024 and WHO Director-General Tedros Adhanom Ghebreyesus on 14 August 2024. It is important to address these announcements openly to
Reference: SA Vaccine Injury Medco-Legal Study Group – SAVIMS. (2024, August 18). Statement on proposed emergency roll-out of vaccine program in Africa for monkeypox. Johannesburg, South Africa. Retrieved from www.savims.org.za Summary: The SA Vaccine Injury Medco-Legal Study Group (SAVIMS) has expressed significant concerns regarding the proposed emergency rollout of monkeypox vaccines in Africa, as announced
Summary The document outlines the I MASK+ Protocol for COVID 19 prevention and early outpatient treatment, including the use of ivermectin and other medications, as well as general preventive measures like wearing masks and hand hygiene. It emphasises the importance of vaccines and early treatment in consultation with healthcare providers. The protocol includes dosing guidelines,
Summary The analysis by Steve Kirsch concludes that COVID vaccines are more harmful than beneficial for all age groups and advocates for halting vaccinations in favour of early treatment protocols. The paper calculates the risks of vaccination compared to the assumed benefits and finds that vaccines may kill more people than they save. Various sources,
Summary The latest UK COVID 19 vaccine surveillance report for week 42 shows various vaccines are effective against symptomatic disease, especially the Delta variant. Vaccination coverage is high in older age groups, with reduced transmission risk and lower rates of cases, hospitalisations, and deaths in vaccinated individuals. The report also includes data on emergency care
Summary This study examined early ambulatory multidrug therapy for high risk COVID 19 patients to reduce hospitalisation and death rates. The research included 869 cases, with 320 cases from April to September 2020 and 549 cases from September to December 2020. The treatment protocol involved antiviral agents, antibiotics, inhaled medications, and intravenous supplements. In the